Skin barrier study for diabetes device users
Part of Hormones & metabolism, Immune system & allergy, Skin clinical trials.
This study looks at how diabetes devices like insulin pumps or continuous glucose monitors affect the skin barrier. If you have type 1 diabetes and use one of these devices, you may be able to help researchers understand skin health better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with type 1 diabetes
- You use a diabetes device that attaches to your skin, like an insulin pump or a continuous glucose monitor (CGM)
- You can read and understand Swedish or English
- You are able to answer questionnaires and be reached by phone
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether special patches placed under insulin pumps or glucose monitors can prevent or reduce skin irritation (contact dermatitis) in children and teens with type 1 diabetes.
This study tests how accurate a new continuous glucose monitor (CGM) called CareSens Air 3 is for adults with type 1 diabetes. You would wear the sensor on your skin to track blood sugar levels, and it may help you manage your diabetes more easily.
This study uses a wearable sensor (like a smartwatch) to track your body's signals when blood sugar drops low. The goal is to understand low blood sugar patterns better, which may help improve prevention and treatment.
This trial tests a new continuous glucose monitor (CGM) designed to help manage blood sugar levels. You will wear the device for 15 days and attend three clinic visits to see how well it works.
This study tests a system that measures blood sugar and automatically adjusts insulin delivery. It is for adults with type 1 diabetes who use insulin injections or a pump.
This study looks at small blood vessel disease (microangiopathy) in people with type 1 diabetes. It will use special devices to examine your skin and blood vessels to understand how diabetes affects them.
Hear when a new Type 1 Diabetes Mellitus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.